METHOCEL™ Premium DC2 Cellulose Ethers
Now available as directly compressible grades, METHOCEL™ DC2 polymers deliver exceptional flow properties and process capability as well as consistent modified release performance for matrix formulations. METHOCEL DC2 will enable manufacturers to replace costly wet granulation in matrix tablet production with cost effective dry granulation and direct compression techniques.
METHOCEL DC2 helps you enjoy the benefits of dry powder processing techniques:
- improved powder flow
- lower manufacturing costs by up to 60%
- shorten development time
- results in more reproducible and robust tablet properties
- better formulation option for heat and moisture-sensitive APIs
- no additives, means no regulatory hurdles, as METHOCEL DC2 is pure HPMC
Three direct compression grades of METHOCEL DC2 are now available: K100 LV, K4M and K100M; chemically identical to current METHOCEL Premium products and meet USP, PhEur and JP specifications.
Colorcon, through the Controlled Release Alliance, has exclusive, global sales and distribution rights for METHOCEL products from DuPont for use in controlled release applications.
METHOCEL™ is a registered trademark of DuPont or its affiliates.
Tablet design service helping companies worldwide differentiate their products for improved patient safety and brand recognition.Discover More
Unique, confidential service, providing our customers with starting formulations for the immediate and extended release of drug from solid oral dosages.Discover More